Megna Michael R’s Kiniksa holdings moved through awards, option exercises, a forfeiture and a sale, with 4,600 shares sold at $80.30 per share and 29,062 shares remaining. The disclosed sequence gives investors the latest ownership count and records both Equity and derivative-security activity tied to the chief accounting officer.

Key Highlights

  • Megna Michael R received 279 Kiniksa shares at $33.50 per share on 15 July 2026.
  • Option exercises for 11,496 shares lifted his reported ownership to 39,193 shares on 1 September 2026.
  • A forfeiture of 5,531 shares at $79.28 per share reduced ownership to 33,662 shares.

Megna Michael R, chief accounting officer of Kiniksa Pharmaceuticals International, plc, sold 4,600 shares at $80.30 per share on 3 September 2026. The transaction left him with 29,062 shares. His reported activity also included awards, option exercises and a share forfeiture.

Awards, Options and Forfeiture Transactions

An award of 279 Kiniksa shares at $33.50 per share on 15 July 2026 left Megna Michael R with 27,697 shares. On 1 September 2026, he exercised options for 11,496 shares, taking reported ownership to 39,193 shares. He then forfeited 5,531 shares at $79.28 per share, leaving 33,662 shares. Separate derivative-security transactions on 1 September 2026 included awards totaling 18,250 securities at $0 per share. The records also list option exercises involving derivative securities on the same date.